— ABOUT THE FOUNDER
From the Research Bench to the Boardroom
Over 15 years navigating the intersection of drug development, business strategy, and venture capital — across three continents and every stage of the therapeutic lifecycle.
— THE FOUNDER
Paola Torre, Ph.D.
Venture Partner — Aquillius Ventures
Board Member — Life Science Angels
Pharmaceutical Scientist — BioMarin
Postdoctoral Research — UCSF, UPenn, NYU
Ph.D., Biomolecular Sciences — University of Trento, Italy
Over 15 years at the intersection of science and strategy - from the research bench to the boardroom.
— PROVEN IMPACT
A Track Record That Speaks
300+
STARTUPS EVALUATED FOR INVESTMENT POTENTIAL
30+
WORKSHOPS DESIGNED FOR BIOTECH ACCELERATORS
$10+M
DEALS SUPPORTED
15+
PANEL APPEARANCES & JUDGING ROLES
What Sets BioIntegrity Advisory Apart
Independent
Objective, evidence-based analysis with transparent assumptions and context.
Selective
A limited number of engagements to ensure depth and continuity.
Flexible
Consistent frameworks
adapted to each unique situation.
